pubmed-article:1351551 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1351551 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:1351551 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
pubmed-article:1351551 | lifeskim:mentions | umls-concept:C0034537 | lld:lifeskim |
pubmed-article:1351551 | lifeskim:mentions | umls-concept:C1704410 | lld:lifeskim |
pubmed-article:1351551 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:1351551 | pubmed:issue | 8809 | lld:pubmed |
pubmed-article:1351551 | pubmed:dateCreated | 1992-7-21 | lld:pubmed |
pubmed-article:1351551 | pubmed:abstractText | The success of radiotherapy depends on the total radiation dose, which is limited by the tolerance of surrounding normal tissues. Since there is substantial variation among patients in normal-tissue radiosensitivity, we have tested the hypothesis that in-vitro cellular radiosensitivity is correlated with in-vitro normal-tissue responses. We exposed skin fibroblast cell lines from six radiation-treated patients to various doses of radiation and measured the proportions surviving. There was a strong relation between fibroblast sensitivity in vitro and normal-tissue reactions, especially acute effects. Assessment of radiosensitivity could lead to improved tumour cure rates by enabling radiation doses to be tailored to the individual. | lld:pubmed |
pubmed-article:1351551 | pubmed:language | eng | lld:pubmed |
pubmed-article:1351551 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1351551 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:1351551 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1351551 | pubmed:month | Jun | lld:pubmed |
pubmed-article:1351551 | pubmed:issn | 0140-6736 | lld:pubmed |
pubmed-article:1351551 | pubmed:author | pubmed-author:PeacockJ HJH | lld:pubmed |
pubmed-article:1351551 | pubmed:author | pubmed-author:TuressonII | lld:pubmed |
pubmed-article:1351551 | pubmed:author | pubmed-author:YarnoldJ RJR | lld:pubmed |
pubmed-article:1351551 | pubmed:author | pubmed-author:WurmRR | lld:pubmed |
pubmed-article:1351551 | pubmed:author | pubmed-author:BurnetN GNG | lld:pubmed |
pubmed-article:1351551 | pubmed:author | pubmed-author:NymanJJ | lld:pubmed |
pubmed-article:1351551 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1351551 | pubmed:day | 27 | lld:pubmed |
pubmed-article:1351551 | pubmed:volume | 339 | lld:pubmed |
pubmed-article:1351551 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1351551 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1351551 | pubmed:pagination | 1570-1 | lld:pubmed |
pubmed-article:1351551 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:meshHeading | pubmed-meshheading:1351551-... | lld:pubmed |
pubmed-article:1351551 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1351551 | pubmed:articleTitle | Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. | lld:pubmed |
pubmed-article:1351551 | pubmed:affiliation | Radiotherapy Research Unit, Institute of Cancer Research, Sutton, Surrey, UK. | lld:pubmed |
pubmed-article:1351551 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1351551 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1351551 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1351551 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1351551 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1351551 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1351551 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1351551 | lld:pubmed |